A detailed history of Tower Research Capital LLC (Trc) transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,297 shares of CARA stock, worth $1,642. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,297
Previous 22,527 76.49%
Holding current value
$1,642
Previous $5,000 80.0%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.26 - $0.38 $4,479 - $6,547
-17,230 Reduced 76.49%
5,297 $1,000
Q2 2024

Aug 13, 2024

BUY
$0.24 - $0.92 $2,664 - $10,213
11,102 Added 97.17%
22,527 $5,000
Q1 2024

May 15, 2024

SELL
$0.52 - $1.05 $1,856 - $3,749
-3,571 Reduced 23.81%
11,425 $10,000
Q4 2023

Feb 13, 2024

BUY
$0.6 - $1.65 $4,032 - $11,089
6,721 Added 81.22%
14,996 $11,000
Q3 2023

Nov 14, 2023

SELL
$1.67 - $3.33 $1,327 - $2,647
-795 Reduced 8.77%
8,275 $13,000
Q2 2023

Aug 14, 2023

BUY
$2.83 - $4.94 $13,855 - $24,186
4,896 Added 117.3%
9,070 $25,000
Q1 2023

May 09, 2023

SELL
$4.89 - $12.27 $66,225 - $166,172
-13,543 Reduced 76.44%
4,174 $20,000
Q4 2022

Feb 10, 2023

BUY
$8.88 - $12.77 $47,623 - $68,485
5,363 Added 43.41%
17,717 $191,000
Q3 2022

Nov 10, 2022

BUY
$8.24 - $12.56 $45,921 - $69,996
5,573 Added 82.19%
12,354 $116,000
Q2 2022

Aug 15, 2022

BUY
$7.45 - $13.84 $5,490 - $10,200
737 Added 12.19%
6,781 $62,000
Q1 2022

May 12, 2022

SELL
$9.94 - $12.65 $15,735 - $20,024
-1,583 Reduced 20.76%
6,044 $73,000
Q4 2021

Feb 14, 2022

SELL
$11.99 - $18.14 $123,233 - $186,442
-10,278 Reduced 57.4%
7,627 $93,000
Q3 2021

Nov 15, 2021

BUY
$11.55 - $16.06 $172,256 - $239,518
14,914 Added 498.63%
17,905 $277,000
Q2 2021

Aug 16, 2021

SELL
$12.38 - $29.19 $11,538 - $27,205
-932 Reduced 23.76%
2,991 $43,000
Q1 2021

May 17, 2021

BUY
$15.07 - $21.71 $572 - $824
38 Added 0.98%
3,923 $85,000
Q4 2020

Feb 16, 2021

SELL
$12.72 - $16.16 $259,055 - $329,114
-20,366 Reduced 83.98%
3,885 $59,000
Q3 2020

Nov 16, 2020

BUY
$12.34 - $17.92 $222,613 - $323,276
18,040 Added 290.45%
24,251 $308,000
Q2 2020

Aug 13, 2020

BUY
$12.39 - $17.33 $76,954 - $107,636
6,211 New
6,211 $106,000
Q1 2020

May 15, 2020

SELL
$9.12 - $17.78 $59,106 - $115,232
-6,481 Closed
0 $0
Q4 2019

Feb 07, 2020

BUY
$16.11 - $25.98 $102,797 - $165,778
6,381 Added 6381.0%
6,481 $104,000
Q3 2019

Nov 05, 2019

BUY
$18.28 - $26.91 $1,828 - $2,691
100 New
100 $2,000
Q2 2019

Aug 13, 2019

SELL
$17.68 - $21.57 $7,195 - $8,778
-407 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$14.41 - $19.64 $5,864 - $7,993
407 New
407 $8,000
Q3 2018

Nov 13, 2018

SELL
$17.57 - $23.95 $808 - $1,101
-46 Closed
0 $0
Q2 2018

Aug 15, 2018

SELL
$11.6 - $19.27 $545 - $905
-47 Reduced 50.54%
46 $1,000
Q1 2018

May 15, 2018

BUY
$11.77 - $16.08 $1,094 - $1,495
93 New
93 $1,000

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $16.7M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.